FOXO:NYE-FOXO Technologies Inc. (USD)

COMMON STOCK | Health Information Services |

Last Closing

USD 0.4008

Change

0.00 (0.00)%

Market Cap

N/A

Volume

0.73M

Analyst Target

N/A
Analyst Rating

N/A

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2025-06-01 )

Largest Industry Peers for Health Information Services

Symbol Name Price(Change) Market Cap
DOCS Doximity Inc

+2.01 (+3.90%)

USD 11.11B
WEAV Weave Communications Inc

+0.23 (+2.45%)

USD 0.72B
AMWL American Well Corp

+0.33 (+5.02%)

USD 0.11B
CTEV Claritev Corporation

-0.66 (-1.73%)

N/A
HNGE Hinge Health, Inc.

-0.11 (-0.27%)

N/A
EVH Evolent Health Inc

+0.98 (+12.95%)

N/A
PHR Phreesia Inc

+0.87 (+3.49%)

N/A
TDOC Teladoc Inc

+0.19 (+2.77%)

N/A
VEEV Veeva Systems Inc Class A

+6.12 (+2.20%)

N/A

ETFs Containing FOXO

N/A

Market Performance

  Market Performance vs. Industry/Classification (Health Information Services) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 37.59% 100% F 97% N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return 37.59% 100% F 97% N/A
Trailing 12 Months  
Capital Gain -15.67% 50% F 18% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -15.67% 50% F 16% F
Trailing 5 Years  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Average Annual (5 Year Horizon)  
Capital Gain -6.73% 40% F 11% F
Dividend Return -6.73% 40% F 9% A-
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 219.31% 20% F 4% F
Risk Adjusted Return -3.07% 50% F 23% F
Market Capitalization N/A N/A N/A N/A N/A

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:

There is nothing we particularly like

What to not like:
Poor risk adjusted returns

This company is delivering below median risk adjusted returns in its peers. Even if it is outperforming on returns , the returns are unpredictable. Proceed with caution.

Below median dividend returns

The company’s average income yield over the past 5 years has been low compared to its peers. However, it is not a problem if you are not looking for income.

High volatility

The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.